In this respect, it is interesting to note that interactions between the mTOR and the STAT pathways are known to take place in immune cells [15], suggesting that our observations on the roles of STAT3 and STAT1 in mediating PD-L1 activities in breast cancer may be connected to the activation of the mTOR axis. The gene discussed is STAT3; the disease is breast carcinoma.